These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 32027768

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice Needs.
    Russo J, McDougall C, Bowler N, Shimada A, Gross L, Hyatt C, Kelly WK, Calvaresi A, Handley NR, Hirsch IH, Izes JK, Lallas CD, Mann M, Mark JR, Mille PJ, Preate D, Trabulsi EJ, Tsang M, Chandrasekar T, Weiner PR, Gomella LG, Giri VN.
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34589662
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical Implications of Germline Testing in Newly Diagnosed Prostate Cancer.
    Loeb S, Giri VN.
    Eur Urol Oncol; 2021 Feb; 4(1):1-9. PubMed ID: 33390340
    [Abstract] [Full Text] [Related]

  • 5. TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing.
    Loeb S, Keith SW, Cheng HH, Leader AE, Gross L, Sanchez Nolasco T, Byrne N, Hartman R, Brown LH, Pieczonka CM, Gomella LG, Kelly WK, Lallas CD, Handley N, Mille PJ, Mark JR, Brown GA, Chopra S, McClellan A, Wise DR, Hollifield L, Giri VN.
    JCO Precis Oncol; 2024 Mar; 8():e2300552. PubMed ID: 38452310
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice.
    Giri VN, Walker A, Gross L, Trabulsi EJ, Lallas CD, Kelly WK, Gomella LG, Fischer C, Loeb S.
    Clin Genitourin Cancer; 2022 Apr; 20(2):e104-e113. PubMed ID: 35012874
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.
    Chandrasekar T, Gross L, Gomella LG, Hegarty SE, Leong JY, Giri VN.
    Eur Urol Oncol; 2020 Jun; 3(3):291-297. PubMed ID: 31278035
    [Abstract] [Full Text] [Related]

  • 11. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.
    Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, Daly MB, Mohler JL, Parsons JK, Carroll PR, Pilarski R, Blanco A, Woodson A, Rahm A, Taplin ME, Polascik TJ, Helfand BT, Hyatt C, Morgans AK, Feng F, Mullane M, Powers J, Concepcion R, Lin DW, Wender R, Mark JR, Costello A, Burnett AL, Sartor O, Isaacs WB, Xu J, Weitzel J, Andriole GL, Beltran H, Briganti A, Byrne L, Calvaresi A, Chandrasekar T, Chen DYT, Den RB, Dobi A, Crawford ED, Eastham J, Eggener S, Freedman ML, Garnick M, Gomella PT, Handley N, Hurwitz MD, Izes J, Karnes RJ, Lallas C, Languino L, Loeb S, Lopez AM, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann M, Mille P, Miner MM, Morgan T, Moreno J, Mucci L, Myers RE, Nielsen SM, O'Neil B, Pinover W, Pinto P, Poage W, Raj GV, Rebbeck TR, Ryan C, Sandler H, Schiewer M, Scott EMD, Szymaniak B, Tester W, Trabulsi EJ, Vapiwala N, Yu EY, Zeigler-Johnson C, Gomella LG.
    J Clin Oncol; 2020 Aug 20; 38(24):2798-2811. PubMed ID: 32516092
    [Abstract] [Full Text] [Related]

  • 12. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.
    Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N, Freedman ML, Hamdy FC, Hoffman-Censits J, Hurwitz MD, Hyatt C, Isaacs WB, Kane CJ, Kantoff P, Karnes RJ, Karsh LI, Klein EA, Lin DW, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann MJ, Mark JR, McCue PA, Miner MM, Morgan T, Moul JW, Myers RE, Nielsen SM, Obeid E, Pavlovich CP, Peiper SC, Penson DF, Petrylak D, Pettaway CA, Pilarski R, Pinto PA, Poage W, Raj GV, Rebbeck TR, Robson ME, Rosenberg MT, Sandler H, Sartor O, Schaeffer E, Schwartz GF, Shahin MS, Shore ND, Shuch B, Soule HR, Tomlins SA, Trabulsi EJ, Uzzo R, Vander Griend DJ, Walsh PC, Weil CJ, Wender R, Gomella LG.
    J Clin Oncol; 2018 Feb 01; 36(4):414-424. PubMed ID: 29236593
    [Abstract] [Full Text] [Related]

  • 13. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
    Das S, Salami SS, Spratt DE, Kaffenberger SD, Jacobs MF, Morgan TM.
    J Urol; 2019 Aug 01; 202(2):223-230. PubMed ID: 30730411
    [Abstract] [Full Text] [Related]

  • 14. Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
    Paller CJ, Antonarakis ES, Beer TM, Borno HT, Carlo MI, George DJ, Graff JN, Gupta S, Heath EI, Higano CS, McKay RR, Morgans AK, Patnaik A, Petrylak DP, Rettig MB, Ryan CJ, Taplin ME, Whang YE, Vinson J, Cheng HH, Giri VN, PCCTC Germline Genetics Working Group.
    Clin Genitourin Cancer; 2019 Aug 01; 17(4):275-282.e1. PubMed ID: 31171481
    [Abstract] [Full Text] [Related]

  • 15. Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testing.
    Leader AE, Rebbeck TR, Oh WK, Patel AV, Winer EP, Bailey LO, Gomella LG, Lumpkins CY, Garraway IP, Aiello LB, Baskin ML, Cheng HH, Cooney KA, Ganzak A, George DJ, Halabi S, Hathaway F, Healy C, Kim JW, Leapman MS, Loeb S, Maxwell KN, McNair C, Morgan TM, Prindeville B, Soule HR, Steward WL, Suttiratana SC, Taplin ME, Yamoah K, Fortune T, Bennett K, Blanding-Godbolt J, Gross L, Giri VN.
    BMC Public Health; 2024 Sep 18; 24(1):2533. PubMed ID: 39289635
    [Abstract] [Full Text] [Related]

  • 16. Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.
    Vadaparampil ST, Quinn GP, Miree CA, Brzosowicz J, Carter B, Laronga C.
    Ann Surg Oncol; 2009 Jul 18; 16(7):1973-81. PubMed ID: 19408048
    [Abstract] [Full Text] [Related]

  • 17. Disclosure of genetics research results after the death of the patient participant: a qualitative study of the impact on relatives.
    Ormondroyd E, Moynihan C, Watson M, Foster C, Davolls S, Ardern-Jones A, Eeles R.
    J Genet Couns; 2007 Aug 18; 16(4):527-38. PubMed ID: 17492498
    [Abstract] [Full Text] [Related]

  • 18. Interest in, willingness-to-pay for and willingness-to-recommend genetic testing for prostate cancer among affected men after radical prostatectomy.
    Mayer M, Selig K, Tüttelmann F, Dinkel A, Gschwend JE, Herkommer K.
    Fam Cancer; 2019 Apr 18; 18(2):221-230. PubMed ID: 30229510
    [Abstract] [Full Text] [Related]

  • 19. Genetic testing in prostate cancer management: Considerations informing primary care.
    Giri VN, Morgan TM, Morris DS, Berchuck JE, Hyatt C, Taplin ME.
    CA Cancer J Clin; 2022 Jul 18; 72(4):360-371. PubMed ID: 35201622
    [Abstract] [Full Text] [Related]

  • 20. Genetic Testing Guidelines and Education of Health Care Providers Involved in Prostate Cancer Care.
    Mark JR, McDougall C, Giri VN.
    Urol Clin North Am; 2021 Aug 18; 48(3):311-322. PubMed ID: 34210487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.